Concepts (114)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Genetic Vectors | 6 | 2019 | 311 | 1.570 |
Why?
|
| Amyotrophic Lateral Sclerosis | 5 | 2018 | 99 | 1.380 |
Why?
|
| Genetic Therapy | 3 | 2018 | 291 | 1.050 |
Why?
|
| Disease Models, Animal | 7 | 2020 | 2550 | 0.950 |
Why?
|
| Motor Activity | 3 | 2019 | 621 | 0.740 |
Why?
|
| Substantia Nigra | 2 | 2018 | 102 | 0.700 |
Why?
|
| Neurodegenerative Diseases | 2 | 2018 | 102 | 0.670 |
Why?
|
| Central Nervous System | 2 | 2017 | 107 | 0.670 |
Why?
|
| Glucosylceramidase | 1 | 2019 | 50 | 0.660 |
Why?
|
| Gaucher Disease | 1 | 2019 | 60 | 0.640 |
Why?
|
| Dependovirus | 5 | 2019 | 34 | 0.630 |
Why?
|
| Spinal Cord | 1 | 2019 | 244 | 0.620 |
Why?
|
| Nausea | 1 | 2018 | 47 | 0.620 |
Why?
|
| Medication Therapy Management | 1 | 2018 | 32 | 0.620 |
Why?
|
| Vomiting | 1 | 2018 | 56 | 0.610 |
Why?
|
| Pharmaceutical Services | 1 | 2018 | 47 | 0.610 |
Why?
|
| Sequestosome-1 Protein | 1 | 2017 | 12 | 0.580 |
Why?
|
| Inclusion Bodies | 1 | 2017 | 10 | 0.580 |
Why?
|
| RNA-Binding Protein FUS | 1 | 2016 | 3 | 0.580 |
Why?
|
| Respiration Disorders | 1 | 2016 | 20 | 0.570 |
Why?
|
| Synapsins | 1 | 2016 | 11 | 0.560 |
Why?
|
| Macaca mulatta | 1 | 2015 | 76 | 0.500 |
Why?
|
| DNA-Binding Proteins | 2 | 2018 | 700 | 0.490 |
Why?
|
| MicroRNAs | 1 | 2019 | 447 | 0.480 |
Why?
|
| Antineoplastic Agents | 2 | 2018 | 1070 | 0.430 |
Why?
|
| Brain | 1 | 2019 | 2176 | 0.320 |
Why?
|
| Neoplasms | 1 | 2018 | 1664 | 0.280 |
Why?
|
| HEK293 Cells | 2 | 2017 | 326 | 0.260 |
Why?
|
| Green Fluorescent Proteins | 2 | 2016 | 200 | 0.260 |
Why?
|
| Rats, Sprague-Dawley | 4 | 2018 | 2083 | 0.250 |
Why?
|
| Animals | 11 | 2020 | 20880 | 0.250 |
Why?
|
| Bryostatins | 1 | 2020 | 32 | 0.180 |
Why?
|
| Spatial Learning | 1 | 2020 | 12 | 0.180 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2020 | 59 | 0.170 |
Why?
|
| NIH 3T3 Cells | 1 | 2019 | 65 | 0.170 |
Why?
|
| Protein Kinase C | 1 | 2020 | 270 | 0.160 |
Why?
|
| Administration, Intravenous | 2 | 2017 | 89 | 0.160 |
Why?
|
| Proteostasis | 1 | 2018 | 3 | 0.160 |
Why?
|
| Integrases | 1 | 2018 | 31 | 0.160 |
Why?
|
| Frontotemporal Dementia | 1 | 2018 | 17 | 0.160 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2018 | 55 | 0.160 |
Why?
|
| Gait | 1 | 2019 | 120 | 0.160 |
Why?
|
| Intersectoral Collaboration | 1 | 2018 | 27 | 0.150 |
Why?
|
| Outpatients | 1 | 2018 | 127 | 0.150 |
Why?
|
| Myositis, Inclusion Body | 1 | 2017 | 5 | 0.150 |
Why?
|
| Rats, Transgenic | 1 | 2017 | 24 | 0.140 |
Why?
|
| Pharmacists | 1 | 2018 | 125 | 0.140 |
Why?
|
| Rats | 4 | 2018 | 5300 | 0.140 |
Why?
|
| Mice, Transgenic | 1 | 2020 | 1033 | 0.140 |
Why?
|
| Escape Reaction | 1 | 2016 | 10 | 0.140 |
Why?
|
| Humans | 11 | 2020 | 68549 | 0.140 |
Why?
|
| Acidosis | 1 | 2016 | 31 | 0.140 |
Why?
|
| Gene Transfer Techniques | 1 | 2017 | 173 | 0.140 |
Why?
|
| Paralysis | 1 | 2016 | 35 | 0.140 |
Why?
|
| Muscle Strength | 1 | 2016 | 62 | 0.140 |
Why?
|
| Respiration | 1 | 2016 | 91 | 0.140 |
Why?
|
| Female | 8 | 2018 | 38021 | 0.130 |
Why?
|
| Hypoxia | 1 | 2016 | 169 | 0.130 |
Why?
|
| Papilloma | 1 | 2015 | 8 | 0.130 |
Why?
|
| Molecular Targeted Therapy | 1 | 2016 | 170 | 0.130 |
Why?
|
| Ion Channels | 1 | 2015 | 72 | 0.120 |
Why?
|
| Transfection | 1 | 2016 | 782 | 0.120 |
Why?
|
| Alzheimer Disease | 1 | 2020 | 565 | 0.120 |
Why?
|
| Mitochondrial Proteins | 1 | 2015 | 113 | 0.120 |
Why?
|
| Naphthoquinones | 1 | 2014 | 14 | 0.120 |
Why?
|
| Electromyography | 1 | 2015 | 184 | 0.120 |
Why?
|
| Promoter Regions, Genetic | 1 | 2016 | 614 | 0.120 |
Why?
|
| Fibroblasts | 1 | 2019 | 902 | 0.120 |
Why?
|
| Mice | 4 | 2020 | 8474 | 0.120 |
Why?
|
| Carcinogenesis | 1 | 2015 | 124 | 0.120 |
Why?
|
| Pilot Projects | 1 | 2018 | 1341 | 0.120 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2014 | 88 | 0.120 |
Why?
|
| Paclitaxel | 1 | 2014 | 140 | 0.110 |
Why?
|
| Disease Progression | 1 | 2016 | 1037 | 0.110 |
Why?
|
| Recombinant Proteins | 1 | 2015 | 742 | 0.110 |
Why?
|
| Neurons | 1 | 2018 | 881 | 0.100 |
Why?
|
| Adenocarcinoma | 1 | 2014 | 475 | 0.100 |
Why?
|
| Skin Neoplasms | 1 | 2015 | 375 | 0.090 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2015 | 624 | 0.090 |
Why?
|
| Breast Neoplasms | 1 | 2014 | 1533 | 0.060 |
Why?
|
| Aged | 1 | 2018 | 14842 | 0.050 |
Why?
|
| Middle Aged | 1 | 2018 | 21119 | 0.040 |
Why?
|
| Adult | 1 | 2018 | 21379 | 0.040 |
Why?
|
| Male | 2 | 2018 | 37283 | 0.040 |
Why?
|
| Apoptosis | 2 | 2018 | 1641 | 0.040 |
Why?
|
| Protein Isoforms | 1 | 2020 | 246 | 0.040 |
Why?
|
| In Vitro Techniques | 1 | 2020 | 765 | 0.040 |
Why?
|
| Amyloid beta-Peptides | 1 | 2020 | 191 | 0.040 |
Why?
|
| alpha-Synuclein | 1 | 2018 | 28 | 0.040 |
Why?
|
| Unfolded Protein Response | 1 | 2018 | 70 | 0.040 |
Why?
|
| Dopaminergic Neurons | 1 | 2018 | 46 | 0.040 |
Why?
|
| Cytoplasm | 1 | 2018 | 155 | 0.040 |
Why?
|
| Transduction, Genetic | 1 | 2017 | 81 | 0.040 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2018 | 99 | 0.040 |
Why?
|
| Nanoparticles | 1 | 2020 | 254 | 0.030 |
Why?
|
| Malates | 1 | 2015 | 5 | 0.030 |
Why?
|
| Uncoupling Protein 2 | 1 | 2015 | 18 | 0.030 |
Why?
|
| Pyruvic Acid | 1 | 2015 | 9 | 0.030 |
Why?
|
| Succinic Acid | 1 | 2015 | 9 | 0.030 |
Why?
|
| Dimethyl Sulfoxide | 1 | 2015 | 30 | 0.030 |
Why?
|
| Free Radical Scavengers | 1 | 2015 | 112 | 0.030 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2015 | 381 | 0.030 |
Why?
|
| Oxygen Consumption | 1 | 2015 | 258 | 0.030 |
Why?
|
| Heterografts | 1 | 2014 | 70 | 0.030 |
Why?
|
| Adenosine Triphosphate | 1 | 2015 | 314 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2014 | 294 | 0.030 |
Why?
|
| Drug Interactions | 1 | 2014 | 289 | 0.030 |
Why?
|
| Reactive Oxygen Species | 1 | 2015 | 499 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2014 | 648 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2015 | 1692 | 0.020 |
Why?
|
| Mitochondria | 1 | 2015 | 643 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2014 | 1851 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2018 | 2689 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2015 | 2791 | 0.020 |
Why?
|